[19]
Schirrmacher, V. Quo Vadis Cancer Therapy? Fascinating Discoveries of the Last 60 Years; Lambert Academic Publishing: Riga, 2017.
[23]
Siafaka, P.I. Üstündağ Okur, N.; Karantas, I.D.; Okur, M.E.; Gündoğdu, E.A. Current update on nanoplatforms as therapeutic and diagnostic tools: A review for the materials used as nanotheranostics and imaging modalities. Asian J. Pharm. Sci., 2020, 16(1), 24-46.
[55]
Rao, J.P.; Geckeler, K.E. Polymer Nanoparticles: Preparation Techniques and Size-Control Parameters; Progress in Polymer Science: Oxford, 2011.
[56]
Pinto Reis, C.; Neufeld, R.J.; Ribeiro, A.J.; Veiga, F. Nanoencapsulation I. methods for preparation of drug-loaded polymeric nanoparticles. Nanomedicine: Nanotechnology, Biology, and Medicine, 2006, 2(1), 8-21.
[59]
Kokorina, A.A.; Ermakov, A.V.; Abramova, A.M.; Goryacheva, I.Y.; Sukhorukov, G.B. Carbon nanoparticles and materials on their basis. Colloids and Interfaces, 2020, 4(4), 42.
[61]
Lombardo, D.; Kiselev, M.A. Methods of liposomes preparation: Formation and control factors of versatile nanocarriers for biomedical and nanomedicine application. 2022, 14(3), 543.
[66]
Kakde, D.; Jain, D.; Shrivastava, V.; Kakde, R.; Patil, A.T. Cancer therapeutics-opportunities, challenges and advances in drug delivery. J. Appl. Pharm. Sci., 2011, 1(9), 1-10.
[103]
Alfaifi, M. Y.; Shati, A. A.; Elbehairi, S. E. I.; Fahmy, U. A.; Alhakamy, N. A.; Md, S. Anti-tumor effect of PEG-coated PLGA nanoparticles of febuxostat on A549 non-small cell lung cancer cells. 3 Biotech, 2020, 10(3), 13.
[132]
Li, A.; Zhao, J.; Fu, J.; Cai, J.; Zhang, P. Recent advances of biomimetic nano-systems in the diagnosis and treatment of tumor. Asian J. Pharm. Sci., 2021, 16(2), 161-174.
[151]
Saenz del Burgo, L.; Hernández, R.M.; Orive, G.; Pedraz, J.L. Nanotherapeutic approaches for brain cancer management. Nanomed. Nanotechnol. Biol. Med., 2014, 10(5), e905-e919.
[152]
Bhatt, A.; Gurnany, E.; Modi, A.; Gulbake, A.; Jain, A. Theranostic potential of targeted nanoparticles for brain cancer. Mini-reviews. Med. Chem., 2017, 17(18), 1758-1777.
[153]
Laquintana, V.; Trapani, A.; Denora, N.; Wang, F.; Gallo, J.M.; Trapani, G. New strategies to deliver anticancer drugs to brain tumors. Expert Opin. Drug Deliv., 2009, 6(10), 1017-1032.
[155]
Friedman, H.S.; Kerby, T.; Calvert, H. Temozolomide and treatment of malignant glioma. Clin. Cancer Res., 2000, 6(7), 2585-2597.
[159]
d’Angelo, M.; Castelli, V.; Benedetti, E.; Antonosante, A.; Catanesi, M.; Dominguez-Benot, R.; Pitari, G.; Ippoliti, R.; Cimini, A. Theranostic nanomedicine for malignant gliomas; Frontiers in Bioengineering and Biotechnology. Frontiers Media S.A., 2019, p. 325.
[165]
Onoshima, D.; Yukawa, H.; Baba, Y. Multifunctional quantum dots-based cancer diagnostics and stem cell therapeutics for regenerative medicine. Advanced Drug Delivery Reviews. Elsevier B.V., Amsterdam, 2015, 95, 2-14.
[169]
Sonali; Singh, R.P.; Singh, N.; Sharma, G.; Koch, B.; Singh, S.; Bharti, S.; Rajinikanth, P.S.; Pandey, B.L; Muthu, M.S. RGD-TPGS decorated theranostic liposomes for brain targeted delivery. Colloids Surf. B Biointerfaces, 2016, 147, 129-141.
[172]
Sonkar, R.; Jha, A.; Viswanadh, M.K.; Burande, A.S.; Pawde, D.M.; Patel, K.K.; Singh, M.; Koch, B.; Muthu, M.S. Gold liposomes for brain-targeted drug delivery: Formulation and brain distribution kinetics. Mater. Sci. Eng. C, 2021, 120, 111652.
[180]
van Vlerken, L.E.; Amiji, M.M. Multi-functional polymeric nanoparticles for tumour-targeted drug delivery. Expert Opin. Drug Deliv., 2006, 3(2), 205-216.
[194]
Harbeck, N.; Penault-Llorca, F.; Cortes, J.; Gnant, M.; Houssami, N.; Poortmans, P.; Ruddy, K.; Tsang, J.; Cardoso, F. Breast cancer. Nat. Rev. Dis. Primers, 2019, 5(1), 66.